Phase 2 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You have been diagnosed with kidney cancer (renal cell carcinoma) confirmed by a biopsy
- There is no sign of the cancer having spread to other parts of the body, based on physical examination or scans
- You are not suitable for surgery or other local treatments to remove or destroy the tumor
- You are able to have either an MRI scan or a CT scan with contrast dye
Who may not be able to join:
- You have previously had radiation therapy in an area that would overlap with the area needing treatment in this trial
- You have kidney cancer that has already spread to other parts of the body
- You are female and are currently pregnant or planning to become pregnant during the course of treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sherif Shaaban, MD, Johns Hopkins University
Phone: 202-919-2523
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in kidney function after PROTON-BASED SBRT treatment as assessed by serum creatine levels; Change in kidney function after PROTON-BASED SBRT treatment as assessed by estimated glomerular rate (eGFR) values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.